Ottawa, ON, November 8, 2016—Calian Group Ltd. (TSX:CGY) is pleased to announce that on October 31, 2016 it acquired a small equity position in Cliniconex Inc., an Ottawa-based patient outreach solutions vendor. Calian participated in a recently announced first round for Cliniconex with other seed investors, the Capital Angel Network and Wesley Clover International. As part of the investment, Scott Murray, Vice President of Calian Health Services, has been appointed to the Cliniconex Board of Directors.
A graduate of the L-Spark incubator and accelerator program, Cliniconex has already established integrations and reseller relationships with two of the largest electronic medical records (EMR) vendors in Canada and is growing sales at 35% per quarter. By using Cliniconex, providers can confidently grow their practices without increasing the administrative overhead of maintaining effective communications with their patients.
"Calian is excited to support the Cliniconex platform and the productivity enhancements it offers medical clinics. Calian prides itself on bringing leading-edge health solutions to our customers and our network of Primacy clinic health practitioners," said Scott Murray.
Launched in 2011, the Cliniconex SaaS platform boosts the productivity of medical clinics by automating patient outreach such as booking notifications, reminders, cancellations, surveys and preventative care reminders. Cliniconex not only reduces the administrative burden of these tasks but also facilitates better doctor-patient engagement.
“Healthcare is lagging behind almost every other sector when it comes to leveraging IT. Recently, however, we are seeing more openness to innovation in healthcare and investment in IT to help increase productivity, better engage with patients, and measure patient outcomes,” says Anthony Mar, CEO of Cliniconex.
The global patient engagement market is estimated to grow to over $13 billion by 2019, according to a recent report from ReportsnReports. Traditional healthcare compensation has been on quantity more than quality and, with the inevitable transition to the latter, it is forcing both healthcare providers and payers to increasingly leverage patient engagement solutions.
“We are pleased to be supporting Ottawa-based innovation,” said Kevin Ford. “This investment is not only local but supports Calian's growth pillars of customer diversification and service line evolution. While such investments are not normal course for Calian, as part of our growth strategy we will be looking to engage with our partners and target markets in new and innovative ways. This investment is representative of that new thinking and we look forward to working with and supporting the team at Cliniconex.”